Tags: Drug.

Anrukinzumab (IMA-638) is a humanized monoclonal antibody designed for the treatment of asthma.Anrukinzumab was developed by Wyeth.

ATC prefix
none
CAS number
910649-32-0
FDA UNII code
OU46IGC49F

Loading...

This page contains content from the copyrighted Wikipedia article "Anrukinzumab"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.